These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10575905)

  • 1. Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?
    Meleady R; Graham I
    Nutr Rev; 1999 Oct; 57(10):299-305. PubMed ID: 10575905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
    Lan X; Dang SN; Zhao YL; Yan H; Yan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K
    Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.
    Kok FJ
    Bibl Nutr Dieta; 2001; (55):189-91. PubMed ID: 11125576
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for risk reduction of cardiovascular disease using homocysteine concentration in blood and plasma as biomarker: support by clinical data.
    Pietrzik K
    Bibl Nutr Dieta; 2001; (55):34-41. PubMed ID: 11125582
    [No Abstract]   [Full Text] [Related]  

  • 13. A statement of homocyst(e)ine and cardiovascular disease.
    Heart and Stroke Foundation of Canada
    Can J Cardiol; 2001 Jul; 17(7):763-6. PubMed ID: 11515496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Combination Folic Acid, Vitamin B
    Stone KL; Lui LY; Christen WG; Troen AM; Bauer DC; Kado D; Schambach C; Cummings SR; Manson JE
    J Bone Miner Res; 2017 Dec; 32(12):2331-2338. PubMed ID: 29244251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ
    Am J Clin Nutr; 1993 Jan; 57(1):47-53. PubMed ID: 8416664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
    Willems HP; den Heijer M; Bos GM
    Semin Thromb Hemost; 2000; 26(3):297-304. PubMed ID: 11011847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?
    Christen WG; Ajani UA; Glynn RJ; Hennekens CH
    Arch Intern Med; 2000 Feb; 160(4):422-34. PubMed ID: 10695683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.
    Taylor BV; Oudit GY; Evans M
    Can Fam Physician; 2000 Nov; 46():2236-45. PubMed ID: 11143583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.